George Magrath's most recent trade in Opus Genetics Inc. was a trade of 392,157 Common Stock done . Disclosure was reported to the exchange on March 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc. | George Magrath | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 392,157 | 1,322,004 | - | - | Common Stock | |
| Opus Genetics Inc. | George Magrath | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 392,157 | 392,157 | - | - | Warrants (right to buy) | |
| Opus Genetics Inc. | George Magrath | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 330,697 | 330,697 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc. | George Magrath | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 330,697 | 929,847 | - | 0 | Common Stock | |
| Opus Genetics Inc. | George Magrath | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 26 Dec 2024 | 100,000 | 599,150 | - | 1.0 | 97,600 | Common Stock |
| Opus Genetics Inc. | George Magrath | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 6,200 | 499,150 | - | 0 | Common Stock | |
| Opus Genetics Inc. | George Magrath | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 15 Nov 2024 | 90,294 | 483,244 | - | 1.0 | 91,215 | Common Stock |
| Opus Genetics Inc. | George Magrath | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 15 Nov 2024 | 9,706 | 492,950 | - | 1.0 | 9,943 | Common Stock |
| Opus Genetics Inc. | George Magrath | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.18 per share. | 01 Nov 2024 | 37,050 | 392,950 | - | 1.2 | 43,719 | Common Stock |
| Opus Genetics Inc. | George Magrath | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 17 May 2024 | 5,000 | 430,000 | - | 1.8 | 8,773 | Common Stock |
| Opus Genetics Inc. | George Magrath | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.96 per share. | 18 Mar 2024 | 25,000 | 425,000 | - | 2.0 | 49,050 | Common Stock |